ATPC Stock Overview
Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Agape ATP Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.23 |
| 52 Week High | US$18.00 |
| 52 Week Low | US$0.21 |
| Beta | 0.44 |
| 1 Month Change | -36.08% |
| 3 Month Change | -51.99% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | -97.04% |
| Change since IPO | -96.16% |
Recent News & Updates
Shareholder Returns
| ATPC | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -17.6% | -1.3% | -3.5% |
| 1Y | n/a | -2.9% | 20.2% |
Return vs Industry: Insufficient data to determine how ATPC performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how ATPC performed against the US Market.
Price Volatility
| ATPC volatility | |
|---|---|
| ATPC Average Weekly Movement | 14.1% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ATPC's share price has been volatile over the past 3 months.
Volatility Over Time: ATPC's weekly volatility has decreased from 36% to 14% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 21 | David How | www.agapeatpgroup.com |
Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. The company offers three series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, and BEAUNIQUE names. Its products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP2 Energized Mineral Concentrate, a nutritional supplement, which supports and enhances nutritional biochemical activities; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1 Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.
Agape ATP Corporation Fundamentals Summary
| ATPC fundamental statistics | |
|---|---|
| Market cap | US$17.89m |
| Earnings (TTM) | -US$2.10m |
| Revenue (TTM) | US$1.43m |
12.4x
P/S Ratio-8.4x
P/E RatioIs ATPC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ATPC income statement (TTM) | |
|---|---|
| Revenue | US$1.43m |
| Cost of Revenue | US$494.52k |
| Gross Profit | US$936.57k |
| Other Expenses | US$3.04m |
| Earnings | -US$2.10m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.027 |
| Gross Margin | 65.44% |
| Net Profit Margin | -146.88% |
| Debt/Equity Ratio | 0% |
How did ATPC perform over the long term?
See historical performance and comparison